Postdoktorand zur Resistenz gegen Radioligand und Strahlentherapie bei Prostatakrebs im Functional Cancer Genomics Lab — USI – Università della Svizzera italiana

Rollenüberblick

Posizione aperta presso Università della Svizzera italiana.

Dipartimento/Istituto: Institute of Oncology Research (IOR).

Ruolo: Postdoctoral position on resistance to radioligand and radiotherapy in prostate cancer in the Functional Cancer Genomics Lab.

PostDoc in the Functional Cancer Genomics laboratory directed by Prof.

Jean- Philippe Theurillat at the IOR – Institute of Oncology Research in Bellinzona, Switzerland The Institute of Oncology Research (IOR) The IOR, affiliated with the Università della Svizzera italiana (USI), is located in a brand-new, high-tech research building that hosts more than 20 different research groups.

It offers state- of-the-art facilities together with the neighboring Institute for Research in Biomedicine (IRB).

It offers a thriving environment with leading edge research projects and multiple occasions of interaction with world leaders in the fields of cancer, immunology, and DNA biology (see Ph.D.

The Functional Cancer Genomics Lab, led by Prof.

Jean-Philippe Theurillat investigates the molecular mechanisms of prostate cancer progression and therapeutic resistance.

The group combines functional genomics, translational pathology, and cutting-edge experimental models to drive discoveries from bench to bedside.